31 Jul 2013: Olsson J, Drott JB, Laurantzon L, Laurantzon O, Bergh A, et al. (2013) Correction: Chronic Prostatic Infection and Inflammation by Propionibacterium acnes in a Rat Prostate Infection Model. PLOS ONE 8(7): 10.1371/annotation/2160e616-aa79-4097-96ab-e143d2a4d136. doi: 10.1371/annotation/2160e616-aa79-4097-96ab-e143d2a4d136 View correction
Chronic inflammation in the prostate, seen as infiltration of inflammatory cells into the prostate gland in histological samples, affects approximately half the male population without indication of prostate disease, and is almost ubiquitous in patients diagnosed with benign prostate hyperplasia and cancer. Several studies have demonstrated the Gram-positive bacterium Propionibacterium acnes to be frequently present in prostate tissue from men suffering from prostate disease. P. acnes has been shown to be associated with histological inflammation in human prostatectomy specimens, and also to induce strong inflammatory response in prostate-derived tissue culture models. The present paper describes a rat model for assessment of the pathogenic potential of P. acnes in prostate. Prostate glands of Sprague Dawley rats (n = 98) were exposed via an abdominal incision and live P. acnes or, in control rats, saline were injected into the ventral and dorso-lateral lobes. Rats were sacrificed 5 days, 3 weeks, 3 months and 6 months post infection, and prostate tissue was analyzed for bacterial content and histological inflammation. Rat sera were assessed for levels of CRP and anti-P. acnes IgG. Live P. acnes could be recovered from the dorso-lateral lobes up to 3 months post infection, while the ventral lobes were cleared from bacteria at that time. In samples up to 3 months post infection, the dorso-lateral lobes exhibited intense focal inflammation. CRP and IgG levels were elevated throughout the span of the experiment, and reached maximum levels 3 weeks and 3 months post infection, respectively. We show that P. acnes have the potential to cause chronic infection in previously healthy prostate, and that the infection has potential to cause chronic histological inflammation in the infected tissue. The high prevalence of P. acnes in human prostate tissue calls for resolution of pathogenic details. The present rat model suggests that complications such as chronic inflammation may be induced by P. acnes infection.
Citation: Olsson J, Drott JB, Laurantzon L, Laurantzon O, Bergh A, Elgh F (2012) Chronic Prostatic Infection and Inflammation by Propionibacterium acnes in a Rat Prostate Infection Model. PLoS ONE 7(12): e51434. doi:10.1371/journal.pone.0051434
Editor: Nancy E. Freitag, University of Illinois at Chicago College of Medicine, United States of America
Received: August 14, 2012; Accepted: November 1, 2012; Published: December 11, 2012
Copyright: © 2012 Olsson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by grants from the County Council of Västerbotten (ALF), (FE), the Medical Faculty of Umeå University (FE), the Lions Cancer Research Foundation and Cancerforskningsfonden Norrland (JO, FE), Percy Falks Stiftelse för forskning beträffande prostatacancer och bröstcancer (JO), and Svenska Läkaresällskapet (SLS-173871, SLS-248771) (JO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Chronic inflammation in the prostate, seen as infiltration of inflammatory cells into the prostate gland in histological samples, affects approximately half the male population without indication of prostate disease , and is almost ubiquitous in patients diagnosed with benign prostate hyperplasia and cancer , . Accumulating evidence suggests that prostatic inflammation contributes significantly to the etiology of prostate cancer ,  as well as benign prostatic hyperplasia (BPH) , . Bacterial colonization and infection of the prostate have been implicated as contributing to the initiation and maintenance of chronic inflammation , , . Asymptomatic or subclinical bacterial infections in the prostate appear to be relatively common, yet largely under-diagnosed , . Several studies have demonstrated high prevalence rates of the Gram-positive bacterium Propionibacterium acnes (P. acnes )in prostate tissue from men diagnosed with prostate disease , , . Serum titres of P. acnes antibodies correlate positively with PSA in cancer-negative patients , thus indicating P. acnes involvement in prostatic inflammation. Furthermore, P. acnes has been shown to be associated with histological inflammation in human prostatectomy specimens  and to induce a strong inflammatory response in prostate derived tissue culture models , . However, well-characterized models of acute and chronic prostate infection are yet to be developed. The present paper describes a rat model of prostatic P. acnes infection for the assessment of acute and chronic infection/inflammation in wild-type animals.
Materials and Methods
Propionibacterium acnes Cultivation
Two batches of Propionibacterium acnes bacteria were cultivated from frozen stock in BHI +5% horse serum at 37°C under microaerophilic conditions; type 1A (CCUG 41530) and a mixture of four human prostate isolates, two of type 1 and two of type 2 , respectively. Exponentially growing bacteria were collected after two passages in fresh medium, washed with sterile saline by centrifugation and resuspended into saline at a density of 1·107 CFU/µl.
Animals and Animal Treatment
Adult male Sprague Dawley rats (age 3–4 months, weight: 400–500 g) (n = 98) (B&K, Stockholm Sweden) were anesthetized with pentobarbital (50 mg/kg) and an incision was made in the lower abdomen to expose the prostate. Propionibacterium acnes (5 µl) (5·107 CFU) (type 1A in animals to be infected for 5 days and 3 weeks, respectively, and prostate isolate-P. acnes mixture in animals to be infected for 3 weeks, 3 months and 6 months, or saline (5 µl) was injected with a Hamilton syringe into the left ventral prostate (VPL) and into the dorso-lateral prostate (DLP) lobes. After 5 days, 3 weeks, 3 months and 6 months, blood samples were collected by cardiac puncture and, subsequently, animals were sacrificed. Left ventral (VPL), right ventral (VPR), and dorso-lateral (DLP) prostate lobes were excised and treated for bacterial counts or fixed in formalin for subsequent histological analysis.
The rats were maintained at the animal facility at Umeå University and all experiments involving animals were approved by the local Animal Review Board (Umeå, Sweden) (approval Ids: 2008/293, date:081029, A81-06, date:060818, A82-06, date:060818). All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering.
Hematoxylin/Eosin- and Immunofluorescence Stainings
Sample tissue was fixed in formalin, dehydrated and embedded in paraffin. Four micron thick sections were deparaffinized and rehydrated. The tissue sections were stained with hematoxylin & eosin according to standard procedures. Tissue was examined for histological inflammation (see below) with an Olympus AX-70 microscope and documented with an ALTRA 20 CCD camera. For IF, deparaffinized sections were antigen-retrieved by boiling in citrate buffer (10 mM, pH 6.0) at 2 atm for 1 h. Following blocking with 1% BSA in PBS, slides were incubated with P. acnes antiserum diluted 1∶1000 in blocking solution for 1 h. Slides were washed in PBS and incubated for 1 h with goat anti-rabbit monoclonal antibodies labeled with alexa 488 (Invitrogen) diluted 1∶1000 in blocking buffer. Following washing and dehydration, the slides were mounted and examined with epifluorescence (Zeiss Axioskop) or confocal fluorescence microscope (Leica). The overlay pictures were created with the Adobe Photoshop software.
Histological Characterization of Inflammation
Slides stained with hematoxylin & eosin were assessed microscopically. Inflammatory patterns were qualitatively categorized as focal or diffuse, and intensity of inflammation was scored based on the amount of infiltrating inflammatory cells. Patterns were categorized as diffuse when covering half the tissue or more, with no sharp borders between inflamed and non-inflamed regions. Patterns were categorized as focal when set off from surrounding normal tissue by clearly defined borders. Intensity of inflammation in each prostate specimen was categorized as minimal (≤5 leukocytes/5000 µm2), moderate (5–50 leukocytes/5000 µm2), or severe (> 50 leukocytes/5000 µm2), based on total leukocyte counts in five randomly selected 1000 µm2 areas. A panel of infected prostate glands illustrates the histological correlates of these criteria (Fig. 1). The volume of inflamed foci, as a percentage of total prostate volume, was determined microscopically by the method described in .
Panel of H&E-stained slides of infected prostate glands that illustrates the histological correlates of the inflammation score criteria, A) minimal inflammation, B) moderate inflammation, C) severe inflammation, D) focal inflammation, E) diffuse inflammation. Magnification: A–C: 100X, D–E: 40X.
Bacterial Counts and P. acnes Biotype Identification
Whole lobes were aseptically homogenized in PBS and 1/10 of the slurry obtained was subjected to 10-fold serial dilutions and plated on anaerobic blood agar plates. Plates were incubated for 1 week in 37°C under anaerobic atmosphere, whereafter P. acnes colonies were counted on the 1–2 plates with maximum resolution for each sample. Strains from biotype 1 & 2 differs in recA gene at base 71 (type 1 = G, type 2 = A), base 183 (type 1 = A, type 2 = G), base 214 (type 1 = C, type 2 = T) and base 424 (type 1 = A, type 2 = G). These SNPs were used to type the recovered isolates. Single colonies were transferred from the anaerobic blood agar plates into 100 µl PBS, and nucleic acid was prepared in a NorDiag Arrow preparation robot, using the Viral N/A extraction kit according to the manufacturer’s instructions (NorDiag AB, Hägersten, Sweden). 1 µl extracted DNA was template for a PCR reaction with primers parecAForw: AGCTCGGTGGGGTTCTCTCATC (0,3 µM) and parecARew: GCTTCCTCATACCACTGGTCATC (0,3 µM) , ABI SYBR Green PCR MasterMix (ABI, Warrington, UK), and water to a final volume of 25 µl. The PCR was performed on a 7900 HT Fast Real-Time PCR System, (Applied Biosystems) with a program consisting of: 95°C, 10 minutes (1 cycle), 95°C 60 s +50°C 30 s +72°C 90 s (35 cycles), 72°C 10 minutes (1 cycle). Sequencing of the PCR product was performed with parecAForw as primer (Eurofins MWG Operońs sequencing service, Eurofins MWG GmbH, Ebersberg, Germany). All sequences could unambiguously be assigned type 1 or type 2. QPCR assessment of P. acnes genome numbers were performed on the remains of the prostate lobe slurry, or, for the animals infected for 6 months that were not directly processed for CFU counts, whole lobes that were stored at −70°C until used. Tissue was disintegrated with a Fast Prep-24 sample preparation system with tubes containing Lysing Matrix M (MP Biomedicals, Solon,Ohio, USA), and nucleic acid was prepared in a NorDiag Arrow preparation robot, using the Viral N/A extraction kit according to the manufacturer’s instructions (NorDiag AB, Hägersten, Sweden). 5 µl (of total 50 µl) extracted DNA was template for a quantitative PCR reaction as described earlier . A standard curve was created from VP lobes from non-infected rats spiked with a defined number of P. acnes bacterial cells (CCUG 41530) prepared from serial dilutions of a liquid broth culture (1.75 109 CFU/ml). The standard curve, tissue processing and qPCR was performed as described above, and the Ct values vs CFU was plotted in a graph described by: CFU = 7E+13e−0,914Ct (R2 = 0,9956). The calculations were performed with MS Excel.
Preparation of Rabbit Anti-Propionibacterium acnes Polyclonal Antiserum
A washed suspension of Propionibacterium acnes in PBS corresponding to approximately 1 109 cells/ml were treated with formaldehyde at a final concentration of 0.01 M. After incubation at 37°C on a slow shaker for 2 h followed by overnight shaking at room temperature, the bacteria were washed three times in PBS and then resuspended in PBS to an optical density of 1 and stored at 4°C. The inactivated bacterial culture was plated on anaerobic blood agar plates and incubated under anaerobic conditions for 10 days. No colonies were detected, indicating that the bacteria were completely inactivated. The inactivated bacteria were used as antigen to raise a polyclonal rabbit antiserum (Agrisera, Umeå, Sweden). The rabbits were maintained at the animal facility at Agrisera and all experiments involving animals were approved by the local Animal Review Board (Umeå, Sweden) (approval Id: A121-06).
Blood Collection and Serological Methods
Blood samples were collected from rats by cardiac puncture prior to sacrifice. After coagulation and centrifugation at 1400 rpm for 10 minutes at room temperature, serum was collected. Presence of anti-P. acnes IgG was assessed by a western blot procedure where the rat serum functioned as the primary antibody. A total bacterial lysate (1·1010 bacterial cells dissolved in 400 µl Sample Buffer) was submitted to SDS-PAGE and electroblotted onto PVDF membrane. The filter was blocked by normal rat serum, cut into strips and incubated for 1 h with individual rat serum diluted 1∶2000. After washing, the strips were collected into a single container and incubated with goat anti-rat HRP antibody (1∶5000) for 1 h, washed and developed with ECC solution (Amersham). CRP levels were determined in an ELISA method (Rat Serum CRP M-1010) according to the manufacturer’s instructions (Alpha diagnostics, San Antonio, TX, USA).
Differences between interval variables and in average intensity scores of IgG were tested for by Student’s t-test. For small samples (n = 3) a permutation test was used . Due to the small sample size, null hypotheses were rejected for p-values equal to 0.05 at the α = 0.05 significance level. Dependencies between categorical variables were tested for by Fisher’s exact test or its extension to larger tables.
Tissue from VPL and DLP in all experimental groups was assessed for the presence of viable P. acnes bacteria. Live bacteria were recovered from the prostate locales of infected animals throughout the duration of the experiment, with decreasing bacterial titers as infection times increased (Fig. 2). 5 days post infection, 6700, 1660 and 4600 CFU were recovered from VPL, and 60500, 215000 and 66000 from DLP. 3 weeks post infection, 10, 0 and 7 CFU were recovered from VPL and 460, 790 and 1360 from DLP of the animals infected with P. acnes type 1A, and 32, 5 and 0 from VPL and 860, 1900 and 6100 from DLP of the animals infected with the P. acnes mixture. 3 months post infection; no bacteria were recovered from VPL, and 0, 10 and 0 from DLP. Bacterial titer counts were significantly higher in DLP than in VPL 5 days post infection (p = 0.05), 3 weeks post infection with type P. acnes 1A (p = 0.05), and 3 weeks post infection with P. acnes mixture (p = 0.05). The possibility that prostate-derived P. acnes isolates would be more potent than P. acnes of type 1A failed to find support in CFU recovery counts 3 weeks post infection (VPL: 1A < mix, p = 0.50, DLP: 1A < mix, p = 0.10). From the rats infected with the P. acnes mix for 3 weeks, 29 recovered bacterial clones, 12 of which from VPL (2 individual rats), and 17 from DLP (3 individual rats), were analyzed for type. Of the VPL isolates, 10/12 were of type 1 and 2/12 were of type 2. Of the DLP isolates, 5/17 were of type 1 and 12/17 were of type 2. Statistical testing for similarity in P. acnes type distributions between VPL and DLP indicated difference (p = 0.00775; (1.53, 137.34) CI of odds ratio). 3 months post infection, 10 bacterial clones (all type 2) were recovered from the DLP of the only rat still harboring live bacteria. No P. acnes could be recovered from control animals. No bacterial count was performed 6 months post infection due to the low bacterial counts 3 months post infection. Quantitative PCR assessment showed presence of P. acnes genomes in both DLP and VPL of all infected animals at 5 days, 3 weeks, 3 months and 6 months post infection. The number of genomes decreased with time after inoculation (Fig. 2). 5 days post infection, 270000, 70000 and 560000 genomes were detected in VPL, and 370000, 300000 and 270000 in DLP. 3 weeks post infection, 460, 80 and 350 genomes were detected in VPL and 18000, 45000 and 24000 in DLP of the animals infected with P. acnes type 1A, and 750, 150 and 460 in VPL and 270000, 11000 and 60000 from DLP of the animals infected with the P. acnes mixture. 3 months post infection, 60, 70 and 35 genomes were detected in VPL, and 300, 650 and 800 in DLP. 6 months post infection two rats were assessed: 50 and 70 genomes were detected in VPL, and 40 and 20 in DLP. Genome counts failed to differ between DLP and VPL 5 days post infection (p = 0.45). However, 3 weeks post infection, counts were significantly higher in DLP than in VPL in rats infected with P. acnes type 1A (p = 0.05), as well as in rats infected with P. acnes mix (p = 0.05). The possibility that prostate-derived P. acnes isolates would be more potent than P. acnes of type 1A failed to find support in genome counts 3 weeks post infection (VPL: p = 0.25, DLP: p = 0.2). Genome counts were significantly higher in DLP than in VPL in rats infected for 3 months (p = 0.05). No hypothesis was tested regarding possible difference between DLP and VPL 6 months post infection, due to the small number of rats.
Amount of P. acnes CFU and genome equivalents retrieved from left ventral prostate lobe (VPL) and dorso-lateral prostate lobe (DLP) 5 days, 3 weeks (1A), 3 weeks (mix), 3 months and 6 months after bacterial instillation. The number of CFU was determined by cultivation on solid agar and genome equivalents were determined by QPCR. Bars represent mean values, and the error bars represent standard deviation. (n = 2–3).
Aortic blood was collected when rats were sacrificed 5 days, 3 weeks (1A & mix), 3 months, and 6 months post infection. Blood serum from infected and control rats were assessed for presence of P. acnes binding IgG and rated 0–3, where 0 represents no P. acnes binding IgG (saline-instilled controls 5 days post infection), and 1–3 are positive in increasing degree. In the control group, all sera scored 0 at 5 days, 3 weeks, 3 months and 6 months post infection (data not shown). All sera scored 0 in the initial sample, 5 days post infection, but non-zero scores were found in subsequent samples (score distribution shown in figure 3). Tests indicated the highest average score in sera collected 3 months post infection (3 m>3 w: p = 0.04; 3 m>6 m: p = 0.0025). No score difference could be attributed to type of infective agent, 1A or mix, 3 weeks post infection (p = 0.45). Serum CRP was quantified 5 days, 3 weeks, 3 months and 6 months post infection. The infected animals had elevated CRP levels throughout the infection period, exhibiting an average of 1.86, 2.00, 2.13, 1.73 and 1.44 times the values of the control animals 5 days, 3 weeks (1A), 3 weeks (mix), 3 months and 6 months, respectively (Fig. 4). Statistical testing indicated difference between infected and controls in all groups (5d: p = 0.002, 3w 1A: p = 0.00, 3w mix: p = 0.00, 3 m: p = 0.02, 6 m: p = 0.02), but no difference could be attributed to type of infective agent, 1A or mix, 3 weeks post infection (p = 0.947).
Serum levels of anti-P. acnes IgG in rats 5 days, 3 weeks (1A), 3 weeks (mix), 3 months and 6 months after instillation. The level of anti-P. acnes IgG was scored in four steps, from 0 (non-detectable) to 3 (maximum level). The diagram shows the distribution of scores among infected rats (n = 9).
Histological Characterization of Inflammation
H&E-stained slides were scored for intensity of inflammation based on counts of infiltrating inflammatory cells, predominantly polymorphonuclear leukocytes in animals infected for 5 days, and lymphocytes in animals infected for 3 weeks, 3 months and 6 months, respectively, (two rats infected for 6 months showed an exception to this pattern and are described further below). Further, inflammation was categorized as focal or diffuse, and volume proportion of inflammatory foci to normal tissue was calculated using a stereological method.
Ventral Prostate Lobe
The left ventral prostate (VPL) exhibited severe diffuse inflammation 5 days post infection in 5/6 infected animals and moderate diffuse inflammation in 1/6 (Fig. 5A). No inflammation was seen in the lobe contra-lateral to the lobe injected with bacteria (VPR) (not shown) or in control animals (Fig. 5A). 3 weeks post infection, moderate diffuse inflammation was seen in VPL in 7/12 of the animals infected with P. acnes type 1A, and in 3/6 animals infected with mix of prostate-derived P.acnes isolates. One of the animals infected with P. acnes mix had severe diffuse inflammation in VPL. Minimal diffuse inflammation was present in the VPR in 4/18 of infected animals (not shown). In controls, 3/17 had minimal diffuse inflammation in VPL (Fig. 5A), and 4/17 had mild diffuse inflammation in VPR (not shown). 3 months post infection, moderate diffuse inflammation was present in VPL in 3/6 (Fig. 5A) and in VPR in 3/6 of infected animals. One rat (1/6) had severe diffuse inflammation in VPL. In controls, 2/6 animals had moderate diffuse inflammation in both VPL (Fig. 5A) and VPR (not shown). 6 months post infection, there was moderate diffuse inflammation in VPL in 2/9 infected animals (Fig. 5A), and in VPR in 1/9 (not shown). In controls, 2/6 had moderate diffuse inflammation in VPL (Fig. 5A), and 1/6 had moderate diffuse inflammation in VPR (not shown). Statistical analysis indicated significant difference between infected and control groups 5 days post infection (p = 0.002479), 3 weeks post infection (1A) (p = 0.04597), 3 weeks post infection (mix) (p = 0.045), but not 3 months (p = 0.5671) and 6 months post infection (p = 1). In addition, no significant difference could be established in inflammatory intensity between the two P. acnes agents 3 weeks post infection (p = 0.5362).
Degree of inflammation in rats 5 days, 3 weeks (1A), 3 weeks (mix), 3 months and 6 months after instillation with P. acnes or PBS. Diagrams A & B show the distribution of scores among rats in each group, with n denoted in the bars. A) Left ventral prostate lobe (VPL), B) Dorso-lateral prostate lobe (DLP). C) Quantitative assessment of the spatial extent of focal inflammation in inflamed DLP. The diagram shows the individual distribution and means for the five groups (n = 5, 4, 3, 2, 2).
Dorso-lateral Prostate Lobe
In infected dorso-lateral prostate (DLP), inflammation was severe and focal in 5/6 animals, 5 days post infection. In these animals, 11–33% (mean: 20%) of the DLP volumes were inflamed (Fig. 5B+C). No inflammation was present in control animals. 3 weeks post infection, severe focal inflammation was present in 10/12, and moderate focal inflammation was present in 1/12 animals infected with P. acnes type 1A (Fig. 5B). Inflamed foci constituted 3–25% (mean: 12.8%) of the total DLP volume. Severe focal inflammation was present in 5/6 animals infected with P. acnes mix, and inflamed foci constituted 9–20% (mean 14%) of total DLP volume (Fig. 5 B+C). No inflammation was present in controls. 3 months post infection, severe focal inflammation was present in 2/6 infected animals. Inflamed foci constituted 8–10% (mean 9%) of the total DLP volume (Fig. 5 B+C). No inflammation was present in controls. 6 months post infection, severe focal inflammation was present in 1/9, and moderate focal inflammation in 1/9 infected animals (Fig. 5B). Inflamed foci constituted 3–5% (mean 3.75%) of the total DLP volume (Fig. 5 B+C). Uniquely for these animals, polymorphonuclear leukocytes formed the bulk of inflammatory infiltrate (Fig. 6). In one animal, structures resembling corpora amylacea were situated in conjunction with the inflammatory foci (Fig. 6).
H&E-staining of inflamed foci in DLP 6 months after P. acnes instillation. Polymorphonuclear leukocytes are forming inflammatory infiltrate that surround structures resembling corpora amylacea. Magnification 400X.
Statistical analysis indicated significant difference between infected and control groups 5 days (p = 0.01515), 3 weeks (1A) (p = 0), 3 weeks (mix) (p = 0.0001783) post infection, but not 3 months (p = 0.4545) nor 6 months post infection (p = 1). There was no significant difference in inflammatory intensity between the two P. acnes agents 3 weeks post infection (p = 1).
Visualization of P. acnes in Prostate Tissue
Sequential sections of VPL and DLP from infected animals and controls were stained with H&E and P. acnes-specific immunofluorescence, respectively. Bacteria could be detected by microscopy in DLP up to 3 months and in VPL up to 3 weeks post infection. Bacteria were seen both in stroma and in epithelial glands, and the presence of bacteria co-localized with foci of histological inflammation (Fig. 7). No bacteria were seen in controls.
Sequential sections of DLP from infected animals at 5 days (A), 3 weeks (B) and 3 months (C) after instillation, stained with H&E (1) and P. acnes- specific immunofluorescence (2). Pictures A3, B3 and C3 are created by overlaying 1 & 2. Pictures A4, B4 and C4 are close-ups of pictures A2, B2 and C2 captured with confocal microscopy. Magnification: 1–3∶100X, 4∶630X.
We have established a novel rat model to investigate the pathogenic features of P. acnes infections of the prostate gland. Accumulating evidence for frequent presence of P. acnes in human diseased prostate tissue, combined with the widely accepted hypothesis that prostatic inflammation is a significant etiologic factor in both prostate cancer and benign prostatic hyperplasia (BPH), a characterization of the properties of this specific bacterial infection is highly relevant to the understanding of disease development. Instillation of 5·107 CFU P. acnes into the prostate gland did not provoke any overt signs of disease, a fact that demonstrates the low direct pathogenicity of this bacterium. The infection initially caused a strong acute histological inflammation in both VP and DLP, and the inflammatory patterns were different in the two lobes; in DLP the pattern of inflammation was focal but in VP it was diffuse. In DLP the initial acute inflammation was succeeded by chronic inflammation that persisted in approximately 1/3 of the animals examined 3 months post infection. Bacterial cells were associated with inflammatory foci, and live bacteria could be retrieved from 1 out of 3 animals 3 months post infection. In VP, on the other hand, the initial acute state evolved into low grade inflammation. At an early stage, 3 weeks post infection, bacteria were only seen in a minority of animals, and only low numbers of live bacteria could be cultivated. The differences between lobes may suggest that the DLP is innately more susceptible for bacterial infections than is the VP. Similar conclusions have been drawn in studies of rodents experimentally infected with E. coli , . Recent research suggests that clonal subpopulations of P. acnes carry specific virulence traits . Studies have reported that P. acnes isolates derived from prostate are genetically and biochemically distinct from skin isolates, and that isolates derived from malignant prostate tissue are predominantly of type 2 , . We infected rats with either prostate- or non-prostate derived P. acnes to observe possible differences in infectious or inflammatory properties between the bacteria. In addition, the prostate derived agent contained a mixture of 2 strains of biotype 1, and 2 strains of biotype 2. There were no differences between prostate and non-prostate isolates regarding severity of inflammation or remaining bacterial load 3 weeks post infection. However, the types distributed differently in prostate lobes; type 2 was more prone to persist in DLP. An interpretation of this result is that a wide range of P. acnes strains have capacity to exert the inflammatory effects observed at this time point, and, in addition, that properties specific to prostate-derived strains may have impact on locale tropism and infectivity. In animals infected with a mixture of isolates, only type 2 isolates could be recovered 3 months post infection. Although the number of recovered bacterial clones, 10 CFU, is too limited to support extensive conclusions regarding increased fitness for type 2 biotype in prostate infections, the result does not rule out this intriguing theory. The mean serum CRP levels of uninfected rats ranged between 280–360 µg/ml during the 6 months time span of the experiment. These values are in line with CRP levels reported for other rat strains . The P. acnes infection caused an increase in serum CRP throughout the studied period, with a peak value of 627 µg/ml 3 weeks post infection. Elevated CRP levels, when prostatic inflammation has declined, are not typical for an acute-phase reaction . The explanations may involve secondary infections, permanent tissue damage or intrinsic properties of this particular rat breed. The humoral immune response against P. acnes was maximal 3 months post infection, when all infected animals had detectable IgG, and a majority of them high titers. 6 months post infection, half the population had lost detectable P. acnes specific IgG, and only 10% had high titers. Sprague-Dawley rats are not prone to spontaneous development of prostatitis. The DLP is reported to stay free of histological inflammation up to one year of age . Other studies report a 16% frequency of spontaneous prostatic inflammation in VP at 6 months of age . Our results support these earlier reports in that the DLPs from our controls were free of inflammation throughout the study time up to 9–10 (3–4+6) months. VPs in controls exhibited spontaneous inflammation debuting at approximately 4 months of age, and at 9–10 months of age one third of animals were inflamed. Further studies are required to describe the molecular differences between prostate lobes responsible for this histological pattern. Recently, several mouse prostate infection models with uro-pathogenic E. coli have been published , , , . Interestingly, the E. coli mouse models generate evidence of infection-dependant pre-cancerous tissue transformations , and reactive hyperplasia as well as increased epithelial proliferation . Given the similarities in the prostatic inflammatory responses to P. acnes in our data and to E. coli infections reported in these studies, such adverse complications upon P. acnes infections of prostate may not be ruled out. Further studies are needed to assess the consequences of this chronic infection at cellular and tissue level. While it is beyond the scope of the present study to resolve the cellular identity of the inflammatory infiltrates, the observed aggregate of PMNs surrounding solid structures in the glandular lumen of DLP 6 months post infection (Fig. 6) may yet be of interest. Corpora amylacea (CA) inclusions in prostate glands are known to mainly consist of amyloid forms of proteins originating from neutrophil granules as reported by us and others , . We suggest that figure 6 captures an early stage in the formation of CA, where neutrophiles have clustered, allowing their granule content to aggregate into a solid structure.
P. acnes generate a self-limiting chronic inflammation in the prostate of rats. Thus, it is a potentially useful model system for general studies on long-term effects of infectious inflammation on prostate health. Upon P. acnes challenge, the prostate lobes differ in inflammatory response and bacterial clearance, a finding that is interesting to translate into a human system where predominantly the peripheral zone is affected by chronic inflammation.
The authors wish to express their gratitude to Patrik Bergström for assistance with statistical analysis, and Sigrid Kilter, Birgitta Ekblom, Elisabeth Dahlberg and Pernilla Andersson for skilful technical assistance.
Conceived and designed the experiments: JO JBD AB FE. Performed the experiments: JO JBD LL OL. Analyzed the data: JO JBD AB FE. Contributed reagents/materials/analysis tools: JO AB FE. Wrote the paper: JO JBD LL FE.
- 1. Delongchamps NB, de la Roza G, Chandan V, Jones R, Sunheimer R, et al. (2008) Evaluation of prostatitis in autopsied prostates–is chronic inflammation more associated with benign prostatic hyperplasia or cancer? The Journal of urology 179: 1736–1740.
- 2. Nickel JC (2008) Inflammation and benign prostatic hyperplasia. Urol Clin North Am 35: 109–115; vii.
- 3. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073–1081.
- 4. De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. The American journal of pathology 155: 1985–1992.
- 5. Palapattu GS, Sutcliffe S, Bastian PJ, Platz EA, De Marzo AM, et al. (2005) Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 26: 1170–1181.
- 6. Kramer G, Mitteregger D, Marberger M (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? European urology 51: 1202–1216.
- 7. Sutcliffe S, Platz EA (2008) Inflammation and prostate cancer: a focus on infections. Curr Urol Rep 9: 243–249.
- 8. Cheng I, Witte JS, Jacobsen SJ, Haque R, Quinn VP, et al. (2010) Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men’s Health Study. PLoS One 5: e8736.
- 9. Nickel JC, Xiang J (2008) Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. J Urol 179: 1391–1395.
- 10. Hochreiter WW, Duncan JL, Schaeffer AJ (2000) Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J Urol 163: 127–130.
- 11. Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, et al. (2008) A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68: 306–320.
- 12. Alexeyev O, Bergh J, Marklund I, Thellenberg-Karlsson C, Wiklund F, et al. (2006) Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden). Cancer Causes Control 17: 1127–1133.
- 13. Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL (2005) Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J Urol 173: 1969–1974.
- 14. Fassi Fehri L, Mak TN, Laube B, Brinkmann V, Ogilvie LA, et al. (2010) Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Int J Med Microbiol.
- 15. Shannon BA, Cohen RJ, Garrett KL (2008) The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men. BJU Int 101: 429–435.
- 16. Drott J, Alexeyev O, Bergstrom P, Elgh F, Olsson J (2010) Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells. BMC Microbiology 10: 126.
- 17. Olsson J, Davidsson S, Unemo M, Mölling P, Andersson S-O, et al. (2012) Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates. APMIS 120: 778–785.
- 18. Halin S, Hammarsten P, Wikstrom P, Bergh A (2007) Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment. The Prostate 67: 370–377.
- 19. McDowell A, Valanne S, Ramage G, Tunney MM, Glenn JV, et al. (2005) Propionibacterium acnes types I and II represent phylogenetically distinct groups. Journal of clinical microbiology 43: 326–334.
- 20. Goldschmidt P, Ferreira CC, Degorge S, Benallaoua D, Boutboul S, et al. (2009) Rapid detection and quantification of Propionibacteriaceae. Br J Ophthalmol 93: 258–262.
- 21. Good PI (2005) Permutation, parametric and bootstrap tests of hypotheses. New York: Springer. xix, 315 p. p.
- 22. Kaplan L, Lee C, Schaeffer AJ (1983) Effect of castration on experimental bacterial prostatitis in rats. The Prostate 4: 625–630.
- 23. Boehm BJ, Colopy SA, Jerde TJ, Loftus CJ, Bushman W (2012) Acute bacterial inflammation of the mouse prostate. The Prostate 72: 307–317.
- 24. Lomholt HB, Kilian M (2010) Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS One 5: e12277.
- 25. de Beer FC, Baltz ML, Munn EA, Feinstein A, Taylor J, et al. (1982) Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology 45: 55–70.
- 26. Naslund MJ, Strandberg JD, Coffey DS (1988) The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. The Journal of urology 140: 1049–1053.
- 27. Sharma OP, Adlercreutz H, Strandberg JD, Zirkin BR, Coffey DS, et al. (1992) Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats. The Journal of steroid biochemistry and molecular biology 43: 557–564.
- 28. Khalili M, Mutton LN, Gurel B, Hicks JL, De Marzo AM, et al. (2010) Loss of Nkx3.1 Expression in Bacterial Prostatitis. A Potential Link Between Inflammation and Neoplasia. Am J Pathol.
- 29. Elkahwaji JE, Hauke RJ, Brawner CM (2009) Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. Br J Cancer 101: 1740–1748.
- 30. Elkahwaji JE, Ott CJ, Janda LM, Hopkins WJ (2005) Mouse model for acute bacterial prostatitis in genetically distinct inbred strains. Urology 66: 883–887.
- 31. Yanamandra K, Alexeyev O, Zamotin V, Srivastava V, Shchukarev A, et al. (2009) Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PLoS One 4: e5562.
- 32. Sfanos KS, Wilson BA, De Marzo AM, Isaacs WB (2009) Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 106: 3443–3448.